ebolavirus
highli
pathogen
human
nonhuman
primat
pose
sever
threat
public
health
interferoninduc
transmembran
ifitm
protein
restrict
entri
ebolavirus
influenza
virus
envelop
virus
howev
breadth
mechan
antivir
activ
ifitm
protein
incomplet
understood
employ
ebolaviru
glycoproteinpseudotyp
vector
ebolaviruslik
particl
address
question
show
ifitm
protein
inhibit
cellular
entri
divers
ebolavirus
demonstr
type
interferon
induc
ifitm
protein
express
macrophag
major
viral
target
moreov
show
ifitm
protein
block
entri
influenza
virus
ebolavirus
differ
mechan
provid
evid
antibodi
ifitm
protein
synergist
inhibit
cellular
entri
ebolavirus
result
provid
insight
role
ifitm
protein
infect
ebolavirus
suggest
mechan
antibodi
though
poorli
neutral
vitro
might
contribut
viral
control
vivo
respons
outbreak
sever
diseas
subsaharan
africa
associ
high
case
fatal
rate
addit
ebov
diseas
current
ongo
western
africa
associ
case
death
april
contrast
restv
asian
ebolaviru
might
apathogen
immunocompet
human
african
asian
ebolavirus
infect
bat
serv
natur
reservoir
relat
filoviru
lloviu
viru
llov
genu
cuevaviru
identifi
european
bat
thu
zoonot
transmiss
ebolavirus
human
pose
signific
threat
public
health
understand
virushost
cell
interact
might
yield
insight
viral
spread
pathogenesi
provid
basi
develop
antivir
strategi
interferon
ifn
system
integr
compon
innat
defens
viral
infect
observ
ebolavirus
encod
sever
ifn
antagonist
indic
ifninduc
antivir
effector
molecul
pose
effect
blockad
viral
spread
ifninduc
transmembran
protein
ifitm
shown
display
antivir
activ
filovirus
viral
pathogen
sever
studi
suggest
ifitm
protein
block
host
cell
entri
virus
inhibit
fusion
viral
membran
endosom
membran
thu
ifitm
protein
inhibit
influenza
viru
fluav
entri
stage
hemifus
possibl
induc
accumul
endosom
cholesterol
although
mechan
undisput
polymorph
gene
shown
studi
associ
increas
suscept
sever
influenza
indic
pose
power
block
fluav
spread
infect
human
contrast
present
unclear
whether
ifitm
protein
inhibit
entri
african
asian
ebolavirus
well
llov
whether
express
major
viral
target
cell
final
remain
determin
whether
ifitm
protein
inhibit
host
cell
entri
ebolavirus
fluav
similar
mechan
present
studi
address
question
employ
vector
system
novel
ebovlik
report
particl
analyz
ebolaviru
glycoprotein
gp
driven
entri
target
cell
inhibit
ifitm
protein
human
embryon
kidney
cell
maintain
dulbecco
minim
essenti
medium
supplement
fetal
bovin
serum
paa
uml
penicillin
ml
streptomycin
cytogen
rd
cell
stabli
express
ctermin
fragment
gaussia
luciferas
gluc
gener
select
transfect
cell
dulbecco
minim
essenti
medium
contain
mgml
monocytederiv
macrophag
mdm
cultur
xvivo
medium
lonza
product
human
mdm
monocyteenrich
cell
isol
thrombapheresi
ring
ficol
densiti
gradient
centrifug
amount
platelet
prepar
reduc
centrifug
monocyt
collect
adhesionmedi
enrich
plastic
dish
follow
cultur
monocyt
adhes
medium
roswel
park
memori
institut
medium
supplement
human
fibrindeplet
plasma
antibiot
next
day
cultur
wash
phosphatebuff
salin
cell
detach
seed
monocyt
differenti
medium
xvivo
supplement
human
fibrindeplet
plasma
antibiot
cultur
day
differenti
mdm
control
flow
cytometr
analysi
express
plasmid
encod
gp
vesicular
stomat
viru
vsv
marburg
viru
marv
strain
musok
murin
leukemia
viru
mlv
lassa
viru
lasv
machupo
viru
macv
strain
carvallo
fluav
strain
particl
gener
cell
express
hemagglutinin
ha
neuraminidas
ebov
strain
mayinga
sudv
strain
bonifac
tafv
restv
bdbv
llov
describ
elsewher
retrovir
vector
use
express
ifitm
protein
also
describ
elsewher
rhesu
macaqu
ifitm
homologu
amplifi
polymeras
chain
reaction
pcr
complementari
dna
clone
pqcxip
vector
pqcxip
vector
encod
human
rhesu
macaqu
ifitm
protein
ctermin
myc
tag
gener
pcr
use
mycencod
primer
plasmid
encod
mutant
gener
pcrbase
mutagenesi
describ
elsewher
gener
cyan
fluoresc
protein
cfp
ifitm
sequenc
amplifi
insert
pqcxip
base
enhanc
green
fluoresc
protein
egfp
replac
super
cyan
fluoresc
protein
insert
via
xhoi
ecori
gener
subclon
ifitm
gene
pqcxipifitm
plasmid
via
noti
ecori
therebi
replac
sequenc
encod
previous
describ
nand
ctermin
fragment
human
codonoptim
gluc
synthes
genscript
fragment
encod
ntermin
portion
gluc
glucn
lack
signal
peptid
fuse
cterminu
ebov
lack
stop
codon
use
overlap
extens
pcr
pcr
product
insert
plasmid
pcagg
fragment
encod
glucc
insert
plasmid
integr
pcramplifi
sequenc
verifi
autom
sequenc
analysi
express
ifitm
protein
detect
use
western
blot
analys
monoclon
mous
antibodi
proteintech
polyclon
rabbit
antiifitm
antibodi
proteintech
crossreact
ifitm
protein
equip
ctermin
myc
tag
detect
use
monoclon
antimyc
antibodi
express
detect
mous
monoclon
antibodi
sigma
detect
express
phosphoryl
polyclon
rabbit
antibodi
polyclon
rabbit
antibodi
cell
signal
use
respect
bound
antibodi
visual
horseradish
peroxidaseconjug
secondari
antibodi
reactiv
rabbit
mous
antibodi
dianova
antiserum
use
neutral
experi
produc
immun
rabbit
fusion
protein
product
vector
encod
ifitm
protein
vector
encod
luciferas
viral
gp
studi
describ
elsewher
brief
cell
cotransfect
plasmid
encod
mlv
gagpol
vsvg
pqcxipbas
relat
vector
encod
either
luciferas
ifitm
protein
chloramphenicol
acetyltransferas
cat
control
cultur
medium
exchang
hour
supernat
harvest
hour
transfect
supernat
steril
filter
aliquot
store
prepar
luciferaseencod
vector
normal
compar
transduct
cell
usag
experi
transient
transduc
adher
cell
line
seed
cell
densiti
cell
per
well
plate
adher
cell
transduc
ifitmencod
vector
spinocul
minut
incub
hour
thereaft
cultur
supernat
replac
fresh
medium
subsequ
cell
inocul
luciferasenorm
vector
harbor
viral
gp
studi
incub
hour
afterward
supernat
replac
fresh
cultur
medium
luciferas
activ
cell
lysat
measur
hour
transduct
use
commerci
avail
kit
promega
pjk
analyz
effect
amphotericin
b
antivir
activ
ifitm
protein
treat
cell
amphotericin
b
fisher
bioreag
hour
transduct
luciferaseencod
vector
differenti
human
mdm
stimul
hour
u
human
antigenix
per
millilit
left
untreat
harvest
differ
time
point
control
ifitm
express
cell
transfect
express
ifitm
protein
assess
pseudotyp
bear
ebovgp
fluavha
lasvglycoprotein
precursor
gpc
incub
rabbit
antiserum
rais
ebovgp
correspond
preimmun
serum
cultur
medium
control
dilut
minut
subsequ
pseudotyp
ad
cell
transduct
effici
determin
describ
product
ebovlik
particl
plasmid
encod
viral
envelop
protein
cotransfect
cell
employ
miru
cultur
supernat
harvest
hour
transfect
viruslik
particl
concentr
ultracentrifug
sucros
cushion
use
rotor
target
cell
rd
glucc
transient
transfect
plasmid
encod
cat
control
use
allow
incub
hour
subsequ
cell
seed
plate
incub
hour
spininfect
hour
follow
incub
hour
final
cell
harvest
gluc
activ
cell
lysat
measur
use
commerci
kit
pierc
accord
manufactur
instruct
flow
cytometr
analysi
cell
transduc
express
ifitm
protein
ntermin
fuse
cfp
harvest
hour
transduct
wash
phosphatebuff
salin
fix
paraformaldehyd
subsequ
cfp
signal
transduc
cell
determin
flow
cytometri
first
assess
whether
suscept
inhibit
ifitm
protein
conserv
gp
virus
speci
within
genu
ebolaviru
employ
retrovir
vector
bear
gp
ebolavirus
analyz
transduct
cell
previous
transduc
express
ifitm
protein
cat
neg
control
follow
establish
protocol
cell
line
chosen
cell
readili
transfect
highli
suscept
transduct
mediat
filoviru
gp
express
ifitm
protein
appreci
impact
transduct
mediat
mlvenv
lasvgpc
macvgpc
modestli
reduc
entri
driven
vsvg
wherea
mark
inhibit
fluavhadriven
entri
observ
figur
keep
publish
data
contrast
entri
driven
ebovgp
test
marvgp
inhibit
ifitm
protein
display
somewhat
higher
antivir
activ
figur
upper
panel
despit
compar
express
transduc
cell
figur
experiment
infect
rhesu
macaqu
ebolavirus
marburgvirus
import
anim
model
ebolaviru
diseas
human
therefor
also
determin
whether
ifitm
protein
rhesu
macaqu
express
transduc
cell
inhibit
gpdriven
entri
rhesu
macaqu
genom
encod
encod
two
variant
express
rhesu
macaqu
ifitm
protein
readili
detect
although
express
reduc
compar
figur
ifitm
homologu
rhesu
macaqu
display
antivir
activ
activ
figur
lower
panel
despit
reduc
express
thu
ifitm
protein
human
rhesu
macaqu
origin
block
entri
driven
gp
divers
ebolaand
marburgvirus
cell
cultur
suggest
ifitm
protein
could
act
panfilovir
inhibitor
infect
nonhuman
primat
human
macrophag
earli
sustain
target
ebolaviru
infect
therefor
assess
whether
ifn
treatment
induc
ifitm
express
human
mdm
figur
treatment
mdm
induc
phosphoryl
within
hour
shown
phosphoryl
still
detect
hour
treatment
express
modestli
increas
upon
treatment
strong
increas
observ
upon
treatment
mdm
wherea
ifn
robustli
induc
express
note
antibodi
reactiv
use
preclud
discrimin
signal
final
exposur
mdm
induc
mark
phosphoryl
littl
effect
express
suggest
ifitm
express
human
macrophag
might
mainli
induc
type
ifn
lin
colleagu
recent
show
inhibit
fluavhadriven
host
cell
entri
rescu
treatment
cell
polyen
macrolid
antibiot
amphotericin
b
find
clinic
implic
use
basi
studi
mechan
underli
antivir
activ
ifitm
protein
ask
whether
amphotericin
b
could
also
rescu
ebovgpdriven
host
cell
entri
inhibit
ifitm
protein
amphotericin
b
effect
inhibit
fluavhadriven
entri
markedli
increas
entri
cell
figur
expect
stark
contrast
amphotericin
b
modul
ebovgpdriven
entri
figur
indic
inhibit
fluavhaand
ebovgpmedi
entri
via
differ
mechan
llov
detect
dead
schreiber
bat
miniopteru
schreibersii
spain
potenti
transmiss
human
might
constitut
health
threat
therefor
ask
whether
ifitm
protein
block
llovgpdriven
entri
inde
similar
inhibit
ebovand
llovgpdriven
transduct
observ
upon
express
indic
antivir
activ
ifitm
protein
extend
llov
figur
result
confirm
use
novel
ebovlik
particl
report
system
measur
gluc
transcomplement
upon
deliveri
gluc
fragment
cell
express
complementari
portion
gluc
figur
assay
faith
reproduc
standard
respons
authent
ebov
entri
inhibitor
ammonium
chlorid
neutral
antibodi
data
shown
k
l
g
identifi
determin
requir
antifiloviru
activ
chang
svk
motif
locat
nterminu
conserv
intracellular
loop
amino
acid
residu
aaaa
motif
previous
shown
import
inhibit
virus
ifitm
protein
mutat
svk
appreci
effect
protein
express
figur
abrog
blockad
ebovgpdriven
entri
markedli
augment
transduct
mediat
llovgp
figur
similarli
cellular
entri
ebovlik
particl
bear
llovgp
augment
svk
mutant
express
protein
also
increas
ebovgpdepend
entri
figur
thu
svk
motif
requir
inhibit
ebovgpand
llovgpfacilit
entri
alter
motif
transform
antivir
provir
factor
abbrevi
fluavha
influenza
viru
hemagglutinin
mlvenv
murin
leukemia
viru
b
rdgaussia
luciferas
glucc
cell
transduc
express
human
ifitm
cat
control
spininfect
portion
gluc
viruslik
particl
vlp
bear
indic
gp
luciferas
activ
cell
lysat
determin
mean
sem
shown
experi
conduct
quintupl
sampl
infect
control
cell
set
similar
result
obtain
cell
transfect
express
analyz
c
western
blot
analysi
ifitm
express
transduc
cell
express
wild
mutant
amino
acid
svk
mutat
alanin
analyz
experi
conduct
describ
svksaaaa
mutant
analyz
mean
sem
shown
independ
experi
transduct
control
cell
set
abbrevi
marv
marburg
viru
e
experi
carri
describ
b
svksaaaa
mutant
includ
vlp
bear
gp
serv
neg
control
result
singl
experi
conduct
quintupl
sampl
shown
confirm
separ
experi
error
bar
indic
standard
deviat
antibodi
direct
ebovgp
inhibit
host
cell
entri
might
contribut
control
viral
spread
infect
host
hypothes
ifitm
express
antibodi
direct
gp
might
synergist
inhibit
gpdriven
entri
test
hypothesi
assess
whether
poorli
neutral
antiserum
rais
rabbit
ebovgp
unfold
potent
neutral
activ
target
cell
use
express
ifitm
protein
antiserum
modestli
inhibit
ebovgpdriven
entri
control
cell
reduct
appreci
effect
fluavhaand
lasvgpcdriven
entri
cell
figur
ebovgpmedi
transduct
cell
markedli
reduc
serum
wherea
effect
fluavhaand
lasvgpcdriven
entri
absent
modest
respect
furthermor
roughli
inhibit
ebovgpdriven
entri
express
alon
increas
vector
incub
gpspecif
antiserum
similar
effect
observ
fluavha
lasvgpc
although
augment
inhibit
effici
measur
figur
final
preimmun
serum
modul
transduct
effici
indic
effect
observ
specif
collect
result
suggest
express
gpspecif
antibodi
might
synergist
inhibit
gpdriven
entri
antivir
action
ifninduc
effector
protein
limit
viral
spread
infect
host
understand
mechan
underli
inhibit
might
help
defin
novel
target
intervent
present
studi
demonstr
ifitm
protein
inhibit
host
cell
entri
driven
gp
repres
member
ebolaviru
cuevaviru
genu
within
filovirida
famili
interestingli
ifitm
protein
might
regul
process
either
enhanc
inhibit
gpdriven
entri
mutant
markedli
augment
llovgpdepend
transduct
moreov
evid
obtain
ifitm
protein
might
inhibit
fluav
ebov
entri
via
differ
mechan
ifitmmedi
blockad
entri
driven
fluavha
ebovgp
rescu
amphotericin
b
treatment
final
result
suggest
neutral
antibodi
ifitm
protein
synergist
inhibit
ebovgpfacilit
entri
studi
show
ifitm
protein
express
macrophag
upon
exposur
type
ifn
produc
high
level
context
ebov
infect
moreov
ifitm
express
report
inhibit
host
cell
entri
authent
ebov
marv
present
find
demonstr
entri
vector
pseudotyp
divers
filoviru
gp
also
block
observ
indic
ifitm
protein
might
constitut
panfilovir
defens
infect
host
defens
could
slow
prevent
viral
spread
seem
oper
human
nonhuman
primat
evidenc
blockad
filovirusgpdriven
entri
rhesu
macaqu
ifitm
protein
moreov
panfilovir
inhibit
suggest
filoviru
gp
includ
llovgp
depend
similar
ident
cellular
factor
andor
process
host
cell
entri
notion
agreement
two
recent
report
indic
gp
llov
ebov
use
ident
factor
attach
ctype
lectin
entri
entri
driven
gp
depend
gp
proteolysi
endosom
cystein
proteas
amount
gp
incorpor
viral
particl
seem
modul
ifitm
sensit
thu
retrovir
particl
bear
low
intermedi
high
amount
ebovgp
restvgp
exhibit
compar
suscept
inhibit
ifitm
protein
supplementari
figur
indic
block
impos
ifitm
protein
might
satur
excess
gp
copi
present
virion
surfac
sum
ifitm
protein
compar
activ
entri
driven
filovir
gp
although
subtl
differ
inhibit
effici
might
remain
undetect
owe
limit
resolut
assay
interest
examin
contribut
protein
control
viral
spread
host
ifitm
knockout
mice
might
suitabl
tool
endeavor
find
studi
aminibavilolyae
colleagu
suggest
ifitm
protein
might
inhibit
endosom
entri
envelop
virus
induc
cholesterol
accumul
endosom
membran
howev
subsequ
work
challeng
concept
reduct
endosom
cholesterol
level
rescu
ebovgpdriven
entri
blockad
ifitm
protein
present
studi
shown
recent
studi
reveal
antimycot
compound
amphotericin
b
disabl
ifitmdepend
inhibit
fluav
retroviru
entri
cell
cultur
amphotericin
b
treatment
mice
shown
abrog
control
fluav
infect
underli
mechan
fulli
clarifi
role
membran
fluiditi
suggest
present
studi
show
ifitm
might
block
fluavhaand
ebovgpmedi
entri
via
differ
mechan
sinc
ebovgpdriven
entri
rescu
amphotericin
b
treatment
thu
work
requir
clarifi
gpdriven
entri
inhibit
studi
might
aid
observ
mutat
svk
motifrequir
antiretrovir
activ
antidengu
fluav
activ
potenti
llovgpdriven
entri
suggest
ifitm
protein
might
abl
posit
neg
regul
cellular
process
critic
filoviru
entri
concept
keep
find
human
coronaviru
use
ifitm
protein
cofactor
infecti
viral
entri
target
cell
gp
ebolavirus
sole
target
neutral
antibodi
effici
inhibit
viral
spread
infect
host
appli
postexposur
prophylaxi
observ
otherwis
poorli
neutral
antiserum
direct
gp
synergist
inhibit
ebovgpdriven
entri
although
respons
mechan
remain
elucid
find
suggest
antibodi
unimpress
neutral
capac
standard
cell
cultur
system
instanc
vero
cell
exhibit
low
endogen
ifitm
express
might
still
unfold
substanti
antivir
activ
host
ifitm
express
induc
ifn
context
find
kajihara
colleagu
noteworthi
report
antibodi
unabl
block
cellular
entri
marv
still
display
potent
antivir
activ
block
gppromot
releas
progeni
particl
infect
cell
collect
ifitm
protein
exhibit
broad
activ
ebolavirus
filovirus
clarifi
underli
mechan
might
yield
valuabl
insight
viral
spread
pathogenesi
fact
recent
studi
suggest
blockad
viral
entri
ifitm
protein
might
multifacet
process
ifitm
protein
shown
incorpor
retrovir
envelop
therebi
reduc
infect
progeni
virion
supplementari
materi
avail
journal
infecti
diseas
onlin
http
jidoxfordjournalsorg
supplementari
materi
consist
data
provid
author
publish
benefit
reader
post
materi
copyedit
content
supplementari
data
sole
respons
author
question
messag
regard
error
address
author
